NOTV Inotiv Corporation: Long-Term Debt to Capital Coefficient

Symbol and logo of brand Inotiv Corporation (NOTV)

Inotiv, Inc. (NOTV) preclinical tests are minimally subject to cyclicality due to long-term R&D plans, as illustrated by the long-term debt-to-equity ratio. The 0.00 indicator reflects the most recent value of this metric. The firm's competitive advantage lies in its unique set of research models for biotech startups. Stable demand for medical innovation renders the business a defensive asset, isolated from global macroeconomic shocks.

NOTV - Inotiv Inc Long-Term Debt to Equity over the range 07/04/2022 - 06/21/2026

Comprehensive metric breakdowns and analytics for Inotiv, Inc. (NOTV)

- price and consensus price forecast:
Quote Chart Inotiv Inc|NOTV - Analyst Consensus Forecast
- market capitalization data:
Market Value Inotiv, Inc.|NOTV - Enterprise Value
- book capitalization data:
Book Value per Share Inotiv|NOTV - Company Book Value|Market Value to Book Value inotivco.com|NOTV - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Inotiv, Inc.|NOTV - Long-Term Debt to Capital|Short-Term Debt to Capital inotivco.com|NOTV - Company Total Debt|Debt to Net Assets Ratio Inotiv, Inc.|NOTV - Company Long-Term Liabilities|Amount of Current Liabilities Inotiv
Initial company analysis:NOTV Inotiv Inc
Core merchandise of Inotiv, Inc.

Inotiv, Inc. is facing declining margins due to an oversupply in the CRO market and budget deficits among biotech startups. An analysis of the long-term debt-to-equity ratio allows for an assessment of the company's financial leverage stability. This metric compares liabilities with maturities exceeding one year against net assets. A rising ratio signals a risky dependence on borrowings amid falling revenues. Investors utilize this balance to determine the limit of the debt load.

Main competitors

Long-Term Liabilities to Equity IQVIA Holdings|Laboratory Corporation of America (LH) - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient Medpace Corp (MEDP)|Long-Term Debt to Capital ICLR (ICON Plc)|criver.com - Long-Term Debt to Capital|Long-Term Debt to Equity Evotec (EVO)|FTRE: Long-Term Debt to Capital Coefficient|LFCR (lifecore.com) - Long-Term Debt to Equity|OmniAb Inc (OABI) - Long-Term Debt to Equity Ratio|CDMO (Avid Bioservices, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital catalent.com (CTLT)|Scorpius Holdings (SCPX) - Long-Term Debt to Equity Ratio